Induction of T1 (cytotoxic lymphocyte) and/or T2 (antibody) responses to a mucin-1 tumour antigen

Vaccine

Volumn 15, Issue 14, 1997, Pages 1586-1593

  Lofthouse, Shari A ^a   Apostolopoulos, Vasso ^a   Pietersz, Geoffrey A ^a   Li, Wenjun ^a   McKenzie, Ian F C ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

Author keywords

Immunotherapy; T 1 T 2; Tumour immunity

Indexed keywords

HYBRID PROTEIN; MANNAN; VACCINE; CA 15-3 ANTIGEN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 1;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; IMMUNITY; IMMUNIZATION; IMMUNOTHERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PARASITE; PRIORITY JOURNAL; PROTECTION; TUMOR; AMINO ACID SEQUENCE; ANIMAL; ANTIBODY PRODUCTION; BAGG ALBINO MOUSE; CELL LINE; CYTOTOXIC T LYMPHOCYTE; DOSE RESPONSE; HUMAN; IMMUNOLOGY; MOLECULAR GENETICS;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; CA-15-3 ANTIGEN; CELL LINE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; INTERLEUKIN-1; MANNANS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, CONJUGATE;

EID: 0030611550     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00077-7     Document Type: Article

References (44)

1. Mosmann, T.R. and Coffman, R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annual Review of Immunology 1989, 7, 145-173.
2. + T cells. Immunology Reviews 1991, 123, 209-229.
3. + T cell. Immunology Today 1994, 15, 107-110.
4. Carter, L.L. and Dutton, R.W. Type 1 and type 2: a fundamental dichotomy for all T-cell subsets. Current Opinions in Immunology 1996, 8, 336-342.
5. Cox, F.E.G. and Liew, E.Y. T-cell subsets and cytokines in parasitic infections. Immunology Today 1992, 14, 237-238.
6. Finkelman, F.D. and Urban, J.F. Cytokines: making the right choice. Parasitology Today 1992, 8, 311-315.
7. Parish, C.R. The relationship between humoral and cell-mediated immunity. Transplantation Review 1972, 13, 35-66.
8. Partidos, C.D., Vohra, P. and Steward, M.W. Priming of measles virus-specific CTL responses after immunisation with a CTL epitope linked to a fusogenic peptide. Virology 1996, 215, 107-110,
9. Whalen, R.G., LeClerc, C., Deriaud, E., Schirmbeck, R., Reimann, J. and Davis, H.L. DNA-mediated immmunisation to the hepatitis B surface antigen. Activation and entrainment of the immune response. Annals of the New York Academy of Science 1995, 772, 64-76.
10. Schirmbeck, R., Deml, L., Melber, K., Wolf, H., Wagner, R. and Reimann, J. Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens. Vaccine 1995, 13, 857-865.
11. Apostolopoulos, V., Pietersz, G.A., Loveland, B.E., Sandrin, M.S. and McKenzie, I.F.C. Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 responses. Proceedings of the National Academy of Sciences of the United States of America 1995, 92, 10128-10132.
12. Apostolopoulos, V., Pietersz, G.A. and McKenzie, I.F.C. Cell-mediated immune responses to MUC1 fusion protein coupled to mannan. Vaccine 1996, 14, 930-938.
13. Taylor-Papadimitriou, J., Peterson, J., Arklie, J., Burchell, J., Ceriani, R.L. and Bodmer, W.F. Monoclonal antibodies to epithelium-specific component of human milk fat globule membrane: production and reaction with cells in culture. International Journal of Cancer 1981, 28, 17-21.
14. Harisch, F.G. and Uhlenbruck, G. Structures of neutral O-linked polyactosaminoglycans on human milk mucin. Journal of Biological Chemistry 1989, 264, 872-883.
15. Xing, P.X., Prenzoska, J., Quelch, K. and McKenzie, I.F.C. Second generation anti-MUC1 peptide monoclonal antibodies. Cancer Research 1992, 52, 2310-2317.
16. Xing, P.X., Tjandra, J.J., Reynolds, K., McLaughlin, P.J., Purcell, D.F.J. and McKenzie, I.F.C. Reactivity of anti-human milk fat globule antibodies with synthetic peptides. Journal of Immunology 1989, 142, 3503-3509.
17. Apostolopoulos, V., Xing, P.X., Trapani, J.A. and McKenzie, I.F.C. Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC-1 bacterial fusion protein. British Journal of Cancer 1992, 67, 713-720.
18. Harlow, E. and Lane, D. Antibodies. A Laboratory Manual. Cold Spring Harbor Laboratories, New York, 1988
19. Acres, B., Hareuveni, M., Balloul, J.M. and Kieny, M.P. VV-MUC1 immunisation of mice - immune response and protection against the growth of murine tumours bearing the MUC1 antigen. Journal of Immunotherapy 1993, 14, 136-143.
20. Lefkovits, I. and Waldmann, H. Limiting dilution analysis of the cells of the immune system. I. The clonal basis of the immune response. Immunology Today 1984, 5, 265-272.
21. Taswell, C. Limiting dilution assays for the determination of immunocompetent cell frequencies. Journal of Immunology 1981, 126, 1614-1619.
22. Xing, P.X., Tjandra, S.A., Stacker, S., Teh. J., Thompson, C., McLaughin, J. and McKenzie, I.F.C. Monoclonal antibodies reactive with mucin expressed in breast cancer. Immunology and Cell Biology 1989, 67, 183-185.
23. + T cells: specificity and function. Immunology Review 1988, 101, 39-80.
24. Bretscher, P.A., Wei, G., Menon, J.N. and Bielefeldt-Ohmann, H. Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science 1992, 257, 539-542.
25. Bretscher, P.A. A strategy to improve the efficacy of vaccination against tuberculosis and leprosy. Immunology Today 1992, 13, 342-345.
26. + T helper cell phenotype development in a T cell receptor-xβ-transgenic model. Journal of Experimental Medicine 1995, 182, 0579-1584.
27. Schmitz, J., Assenmacher, M. and Radbruch, A. Regulation of T helper cell cytokine expression: functional dichotomy of antigen presenting cells. European Journal of Immunology 1993, 23, 191-199.
28. Bevan, M.J. Stimulating killer cells. Nature 1989, 342, 478-481.
29. Scott, P.S., Natovitz, P., Pearce, E., Sher, A. and Coffman, R.L. Vaccine-induced Th1 and Th2 subsets either protect or exacerbate leishmanial infection. In Vaccine 89, Cold Spring Harbor Laboratories, New York, 1989, pp. 25-29.
30. Yang, X., Gieni, R.S., Mosmann, T.R. and Hayglass, K.T. Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo. Journal of Experimental Medicine 1993, 178, 349-353.
31. Husband, A.J. Novel strategies for the control of mucosal infection. Vaccine 1993, 11, 107-112.
32. Xu-Amano, J., Kiyono, H., Jackson, R.J., Staats, H.F., Fujihashi, K., Burrows, P.D., Elson, C.O., Pillai, S. and McGee, J. Helper T cell subsets for immunoglobulin A responses: oral immunisation with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. Journal of Experimental Medicine 1993, 178, 1309-1320.
33. Scott, P. and Kaufmann, S.E. The role of T-cell subsets and cytokines in the regulation of infection. Immunology Today 1991, 12, 346-348.
34. Gajewski, T.F., Schell, S.R., Nau, G. and Fitch, F.W. Regulation of T cell activation: differences among T cell subsets. Immunology Review 1989, 111, 79-110.
35. Avrameas, A., McIlroy, D., Hosmalin, A., Autran, B., Debre, P., Monsigny, M., Roche, A.C. and Midoux, P. Expression of a mannose/fucose membrane lectin on human dendritic cells. European Journal of Immunology 1996, 26, 394-400.
36. Andrews, A.E., Lofthouse, S.A., Bowles, V.M., Brandon, M.R. and Nash, A.D. Production and in vivo use of recombinant ovine interleukin-1β as an immunological adjuvant. Vaccine 1994, 12, 14-22.
37. Lofthouse, S.A., Andrews, A.E., Barcham, G.J. and Nash, A.D. Parameters related to the application of recombinant ovine interleukin-1β as an adjuvant. Vaccine 1995, 13, 1277-1287.
38. Sagara, T., Mori, S., Ohkawara, S., Goto, F., Takagi, K. and Yoshinagi, M. A limited role of IL-1 in immune enhancement by adjuvants. Immunology 1990, 71, 251-257.
39. Reddy, D.N., Reddy, P.G., Minocha, H.C., Fenwick, B.W., Baker, P.E., Davis, W.C. and Blecha, F. Adjuvanticity of recombinant interleukin-1β: influence on immunity and latency in a bovine herpesvirus infection. Lymphokine Research 1990, 9, 295-307.
40. Reddy, D.N., Reddy, P.G., Xue, W., Minocha, H.C., Daley, M.J., Davis, W.C. and Blecha, F. Immunopotentiation of bovine respiratory disease virus vaccines by interleukin-1 beta and interleukin-2. Veterinary Immunology and Immunopathology 1993, 37, 25-38.
41. McCune, C.S. and Marquis, D.M. Interleukin 1 as an adjuvant for active specific immunotherapy in a murine tumour model. Cancer Research 1990, 50, 1212-1215.
42. Goff, J.P., Naito, Y., Kehru, M.E., Hayes, P. and Daley, M. Physiologic effects of administration of interleukin-1β in cows. American Journal of Veterinary Research 1992, 53, 1983-1988.
43. Bliss, J., Van Cleave, V., Murray, K., Wiencis, A., Ketchum, M., Maylor, R., Haire, T., Resmini, C., Abbas, A. and Wolf, S.F. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. Journal of Immunology 1996, 156, 887-894.
44. Kelso, A. Th1 and Th2: subsets: paradigms lost? Immunology Today 1995, 16, 374-379.